REGULATORY

• Komeito Lawmakers Propose Review of Off-Year Re-Pricing, Correction of Multi-Product Small-Lot Generic Production
  May 12, 2023

• MOF Continues to See Macroeconomic Indexing Reasonable: Panel Meeting
  May 12, 2023

• LDP Pharma Study Group Eyes Removal of Budget Cap on Social Security Spending
  May 11, 2023

• Nonpartisan Lawmaker League OKs Dementia Bill, Eyes Enactment in Current Diet
  May 11, 2023

• No Additional Safety Measures Needed at this Time for Xocova: Panel
  May 11, 2023

• Label Revisions Ordered for 32 Hypertension Meds to Caution against Fetal Risks
  May 10, 2023

• LDP’s Life Science League Submits Proposal; Ex-Minister Urges Price Debate from Industrial Policy Perspective
  May 10, 2023

• MHLW Panel OKs 197 More Health Damage Claims for COVID Vaccines
  May 10, 2023

• Chuikyo to Go Back Offline from May, but Online Viewing Still Available
  May 9, 2023

• FY2023 COVID Booster Program Begins for Elderly, Health Workers
  May 9, 2023

• Japan Shoots for 80% Replacement Rate in 60% of All Biosimilar APIs by FY2029
  May 8, 2023

• PMDA, NHO Ink Database Deal, Data on 9 Million-Plus People to Be Available
  May 8, 2023

• MHLW to Decide on Policy for Real-Time Supply Info System within FY2023: Official
  May 8, 2023

• Japan Ends Priority Review for COVID Products with Severity Downgrade
  May 8, 2023

• Ferring Japan Faces Biz Improvement Order for GMP Violation at Overseas Site
  May 1, 2023

• Japan Approves Mefeego as First Abortion Pill
  May 1, 2023

• LDP League Calls for Generic Market Entry Rules to Ensure Supply: Draft Proposal
  April 28, 2023

• Outline of Expert Panel Report Calls for New Forum to Discuss Generics’ Future, Revisiting of Spillover Rule
  April 28, 2023

• Lawmakers’ League on Pollen Allergy Boosts Up
  April 27, 2023

• As Japan Mulls Pushing Back Fee Revisions, Chuikyo Reps Fret Impact on Drug Price Updates
  April 27, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 83
• 84
• 85
• 86
• 87
• 88
• 89
• 90
• 91
• …
• Next ›
• 最終 »